An Efficient One Pot Multicomponent Synthesis of Coumarino Pyrazolyl Thiazolidinones

References

• T. M. Pereira, D. P. Franco, F. Vitorio, and A. E. Kummerle, “Coumarin Compounds in Medicinal Chemistry: Some Important Examples from the Last Years,” Current Topics in Medicinal Chemistry 18, no. 2 (2018): 124–48.
   PubMed Web of Science ®Google Scholar
• L. Wu, X. Wang, W. Xu, F. Farzaneh, and R. Xu, “The Structure and Pharmacological Functions of Coumarins and Their Derivatives,” Current Medicinal Chemistry 16, no. 32 (2009): 4236–60.
   PubMed Web of Science ®Google Scholar
• L. Huang, X. Yuan, D. Yu, K. H. Lee, and C. H. Chen, “Mechanism of Action and Resistant Profile of anti-HIV-1 Coumarin Derivatives,” Virology 332, no. 2 (2005): 623–8.
   PubMed Web of Science ®Google Scholar
• H. Li, Y. Yao, and L. Li, “Coumarins as Potential Antidiabetic Agents,” The Journal of Pharmacy and Pharmacology 69, no. 10 (2017): 1253–64.
   PubMed Web of Science ®Google Scholar
• V. Thomas, D. Giles, G. P. M. Basavarajaswamy, A. K. Das, and A. Patel, “ Coumarin Derivatives as Anti-inflammatory and Anticancer Agents,”Anti-Cancer Agents in Medicinal Chemistry 17, no. 3 (2017): 415–23.
   PubMed Web of Science ®Google Scholar
• Y. K. Al-Majedy, A. A. H. Kadhum, A. A. Al-Amiery, and A. B. Mohamad, “Coumarins: The Antimicrobial Agents,” Systematic Reviews in Pharmacy 8, no. 1 (2017): 62–70.
   Google Scholar
• L. da, S. M. Forezi, L. P. Borba-Santos, M. F. C. Cardoso, V. F. Ferreira, S. Rozental, F. de, and C. da. Silva, “Synthesis and Antifungal Activity of Coumarins Derivatives against Sporothrix spp.,” Current Topics in Medicinal Chemistry 18, no. 2 (2018): 164–71.
   PubMed Web of Science ®Google Scholar
• S. M. de Souza, F. D. Monache, and A. Smania, Jr, “Antibacterial Activity of Coumarins,” Zeitschrift fur Naturforschung C 60 (2005): 639–700.
   Web of Science ®Google Scholar
• D. Sibbing, N. Von. Beckerath, T. Morath, J. Stegherr, J. Mehilli, N. Sarafoff, S. Braun, S. Schulz, A. Schomig, and A. Kastrati, “Oral Anticoagulation with Coumarin Derivatives and Antiplatelet Effects of Clopidogrel,” European Heart Journal 31, no. 10 (2010): 1205–11.
   PubMed Web of Science ®Google Scholar
• D. Zavrsnik, S. Muratovic, D. Makuc, J. Plavec, M. Cetina, A. Nagl, E. De Clercq, J. Balzarini, and M. Mintas, “Benzylidene-Bis-(4-Hydroxycoumarin) and Benzopyrano-Coumarin Derivatives: Synthesis, 1H/13C-NMR Conformational and X-ray Crystal Structure Studies and in Vitro Antiviral Activity Evaluations,” Molecules 16 (2011): 6023–40.
   PubMed Web of Science ®Google Scholar
• R. Surendra Kumar, I. A. Arif, A. Ahamed, and A. Idhayadhulla, “Anti-Inflammatory and Antimicrobial Activities of Novel Pyrazole Analogues,” Saudi Journal of Biological Sciences 23, no. 5 (2016): 614–20.
   PubMed Web of Science ®Google Scholar
• H. M. Faidallah, M. M. Al-Mohammadi, K. A. Alamry, and K. A. Khan, “Synthesis and Biological Evaluation of Fluoropyrazolesulfonylurea and Thiourea Derivatives as Possible Antidiabetic Agents,” Journal of Enzyme Inhibition and Medicinal Chemistry 31, no. sup1 (2016): 157–63.
   PubMed Web of Science ®Google Scholar
• G. Ouyang, X. J. Cai, Z. Chen, B. A. Song, P. S. Bhadury, S. Yang, L. H. Jin, W. Xue, D. Y. Hu, and S. Zeng, “Synthesis and Antiviral Activities of Pyrazole Derivatives Containing an Oxime Moiety,” Journal of Agricultural and Food Chemistry 56, no. 21 (2008): 10160–7.
   PubMed Web of Science ®Google Scholar
• G. Kumar, O. Tanwar, J. Kumar, M. Akhter, S. Sharma, C. R. Pillai, M. M. Alam, and M. S. Zama, “Pyrazole-Pyrazoline as Promising Novel Antimalarial Agents: A Mechanistic Study,” European Journal of Medicinal Chemistry 149 (2018): 139–47.
   PubMed Web of Science ®Google Scholar
• R. Kenchappa, Yadav D. Bodke, A. Chandrashekar, M. Aruna Sindhe, and S. K. Peethambar, “Synthesis of Coumarin Derivatives Containing Pyrazole and Indenone Rings as Potent Antioxidant and Antihyperglycemic Agents,” Arabian Journal of Chemistry 10 (2017): S3895–S3906.
   Web of Science ®Google Scholar
• H. B’Bhatt, and S. Sharma, “Synthesis and Antimicrobial Activity of Pyrazole Nucleus Containing 2-Thioxothiazolidin-4-One Derivatives,” Arabian Journal of Chemistry 10 (2017): S1590–S1596.
   Web of Science ®Google Scholar
• R. Ottana, R. Maccari, M. L. Barreca, G. Bruno, A. Rotondo, A. Rossi, G. Chiricosta, R. Di. Paola, L. Sautebin, S. Cuzzocrea, et al. “5-Arylidene-2-Imino-4-Thiazolidinones: Design and Synthesis of Novel anti-Inflammatory Agents,” Bioorganic & Medicinal Chemistry 13, no. 13 (2005): 4243–52.
   PubMed Web of Science ®Google Scholar
• G. Cihan-Üstündağ, E. Gürsoy, L. Naesens, N. Ulusoy-Güzeldemirci, and G. Çapan, “Synthesis and Antiviral Properties of Novel Indole-Based Thiosemicarbazides and 4-Thiazolidinones,” Bioorganic & Medicinal Chemistry 24, no. 2 (2016): 240–6.
   PubMed Web of Science ®Google Scholar
• A. S. Thakur, R. Deshmukh, A. K. Jha, and P. S. Kumar, “Synthesis and Anticonvulsant Effect of Novel Thiazolidinedione Containing Benzene-Sulfonylurea and Sulfonylthiourea Derivatives,” Central Nervous System Agents in Medicinal Chemistry 16, no. 2 (2016): 152–7.
   PubMedGoogle Scholar
• M. Fesatidou, P. Zagaliotis, C. Camoutsis, A. Petrou, P. Eleftheriou, C. Tratrat, M. Haroun, A. Geronikaki, A. Ciric, and M. Sokovic, “5-Adamantan Thiadiazole-Based Thiazolidinones as Antimicrobial Agents. Design, Synthesis, Molecular Docking and Evaluation,” Bioorganic & Medicinal Chemistry 26, no. 16 (2018): 4664–76.
   PubMed Web of Science ®Google Scholar
• R. Z. Batran, A. F. Kassem, E. M. H. Abbas, S. A. Elseginy, and M. M. Mounier, “Design, Synthesis and Molecular Modeling of New 4-phenylcoumarin Derivatives as Tubulin Polymerization Inhibitors Targeting MCF-7 Breast Cancer Cells,” Bioorganic & Medicinal Chemistry 26, no. 12 (2018): 3474–90.
   PubMed Web of Science ®Google Scholar
• E. Yoshida, D. Kudo, H. Nagase, H. Shimoda, S. Suto, M. Negishi, I. Kakizaki, M. Endo, and K. Hakamada, “Atitumor effects of the hyaluronan inhibitor 4-methylumbelliferone on pancreatic cancer” Oncology Letters 12 (2016): 2337–2344.
   PubMed Web of Science ®Google Scholar
• V. S. Tangeti, K. R. Varma, G. V. S. Prasad, and K. V. V. V. Satyanarayana, “Synthesis of C3-Dihydrofuran Substituted Coumarins Via Multicomponent Approach” Synthetic Communications 46 (2016): 613–619.
   Web of Science ®Google Scholar
• Y. Dong, Q. Shi, K. Nakagawa-Goto, P. C. Wu, K. F. Bastow, S. L. Morris-Natschke, and K. H. Lee, “Antitumor agents 269. Non-aromatic ring-A neotanshinlactone analog, TNO, as a new class of potent antitumor agents” Bioorganic & Medicinal Chemistry Letters 19 (2009): 6289–6292.
   PubMed Web of Science ®Google Scholar
• X. Lu, L. Huang, W. Zhang, and X. Ning, “Tepoxalin a dual 5-LOX-COX inhibitor and erlotinib an EGFR inhibitor halts progression of gastric cancer in tumor xenograft mice” American Journal of Translational Research 10 (2018): 3847–3856.
   PubMed Web of Science ®Google Scholar
• J. Yang, S. Wei, D. S. Wang, Y. C. Wang, S. K. Kulp, and C. S. Chen, “Pharmacological Exploitation of the peroxisome Proliferator-Activated Receptor γ Agonist Ciglitazone to Develop a Novel Class of Androgen Receptor-Ablative Agents” Journal of Medicinal Chemistry 51 (2008): 2100–2107.
   PubMed Web of Science ®Google Scholar
• S. S. Gawande, S. C. Warangkar, B. P. Bandgar, and C. N. Khobragade, “Synthesis of New Heterocyclic Hybrids Based on Pyrazole and Thiazolidinone Scaffolds as Potent Inhibitors of Tyrosinase,” Bioorganic & Medicinal Chemistry 21, no. 10 (2013): 2772–7.
   PubMed Web of Science ®Google Scholar
• S. Huber-Villaume, G. Revelant, E. Sibille, S. Philippot, A. Morabito, S. Dunand, P. Chaimbault, D. Bagrel, G. Kirsch, S. Hesse, et al. “2-(Thienothiazolylimino)-1,3-thiazolidin-4-ones Inhibit Cell Division Cycle 25 A Phosphatase,” Bioorganic & Medicinal Chemistry 24, no. 13 (2016): 2920–8.
   PubMed Web of Science ®Google Scholar
• K. Sujatha and R. R. Vedula, “Novel One-Pot Expeditious Synthesis of 2,4-Disubstituted Thiazoles through a Three Component Reaction under Solvent Free Conditions,” Synthetic Communications 48, no. 3 (2018): 302–8.
   Web of Science ®Google Scholar
• K. Sujatha, R. P. Deshpande, R. K. Kesharwani, P. Prakash. Babu, and R. R. Vedula, “An Efficient One-Pot Expeditious Synthesis of 3-Phenyl-1-(6-Phenyl-7H[1,2,4] triazolo [3,4-b][1,3,4]thiadiazin-3-yl)-1H-pyrazol-5-amines via Multicomponent Approach,” Synthetic Communications 49, no. 1 (2019): 49–55.
   Web of Science ®Google Scholar
• K. Sujatha, and R. R. Vedula, “Multicomponent Efficient Synthesis of New [1,2,4] Triazolo [3,4] Thiadiazines,” Journal of Heterocyclic Chemistry 56, no. 3 (2019): 832–8.
   Web of Science ®Google Scholar
• K. Sujatha, and R. R. Vedula, “Polyethylene Glycol (PEG-400) Promoted One-Pot, Five-Component Synthesis of (E)-ethyl-2-(2-((E)-2-(1-(4-methyl-2-(phenylamino)thiazol-5yl)ethylidene)hydrazinyl)-4-oxothiazol-5(4H)-ylidene)Acetates,” Molecular Diversity 24, no. 2 (2020): 413–9.
   PubMed Web of Science ®Google Scholar
• P. Wadhwa, S. Bagchi, and A. Sharma, “A Regioselective Multicomponent Cascade to Access Thiosemicarbazone-Fused Thiazinones: Scope, Structure Elucidation and Gram Scale Synthesis,” Chemistry Select 2, no. 4 (2017): 1386–91.
   Google Scholar